AUD/USD stays on the defensive bellow 0.7300
|- AUD/USD reverses Monday’s 2-month highs above 0.7300.
- Monday’s Pfizer-led rally appears to be losing momentum.
- NAB Business Confidence improved to 5 in October.
Following Monday’s uptick to new 2-month highs beyond 0.73 the figure, AUD/USD meets some selling pressure and recedes to the 0.7260/50 band on turnaround Tuesday.
AUD/USD meets solid hurdle near 0.7340
AUD/USD climbed to the area of 2-month peaks well above the 0.7300 mark at the beginning of the week bolstered by the generalized upbeat sentiment in the risk-associated complex, all in response to the positive news from the vaccines’ front, this time from US pharmaceutical Pfizer (NYSE: PFE).
However, the bout of optimism run out of vigour and motivated the pair to give away those initial gains and close the session with just marginal benefits.
AUD/USD now trades within a consolidative fashion in the mid-0.7200s against the backdrop of an offered bias in the broader risk complex and the steady march in the greenback after Monday’s (very) positive price action.
Earlier in the session, the NAB Business Confidence ticked higher to 5 in October (from -4), while the Business Survey also tracked by NAB improved to 1 (from 0).
AUD/USD levels to watch
At the moment the pair is receding 0.19% at 0.7263 and faces immediate contention at 0.7187 (55-day SMA) seconded by 0.7134 (100-day SMA) and then 0.6991 (monthly low Nov.2). On the other hand, a breakout of 0.7339 (monthly high Nov.9) would aim for 0.7413 (2020 high Sep.1) and finally 0.7453 (monthly high Aug.9 2018).
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.